ReviewHeliyon2024

Clinical effects and mechanisms of a Chinese patent medicine, Tongxinluo capsule, as an adjuvant treatment in coronary heart disease.

Jing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.